MCK
McKesson Corporation
NYSE · Healthcare · Medical - Distribution · US
$907.99
−1.45%Year over year
Reported trailing growth
- Revenue
- +8.8%
- EBITDA
- +37.7%
- EBIT
- +62.1%
- EPS
- +49.0%
- Free cash flow
- +9.2%
- Operating cash flow
- +4.7%
Forward estimates
Based on analyst estimates
- Revenue
- +6.8%
- EBITDA
- +18.3%
- EPS
- +23.5%
Three-year CAGR
- Revenue
- +13.4%
- EBITDA
- +7.8%
- EBIT
- +13.2%
- Net income
- +10.2%
- EPS
- +15.2%
- Free cash flow
- +5.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026